The Role of Neuropeptide-Stimulated cAMP-EPACs Signalling in Cancer Cells
Neuropeptides are autocrine and paracrine signalling factors and mainly bind to G protein-coupled receptors (GPCRs) to trigger intracellular secondary messenger release including adenosine 3′, 5′-cyclic monophosphate (cAMP), thus modulating cancer progress in different kind of tumours. As one of the...
Main Authors: | Zhengyin Gao, Weng I Lei, Leo Tsz On Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/1/311 |
Similar Items
-
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
by: Hongying Zhang, et al.
Published: (2024-01-01) -
cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
by: Muhammad Bilal Ahmed, et al.
Published: (2022-06-01) -
GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure
by: Marion Laudette, et al.
Published: (2021-01-01) -
Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
by: Nshunge Musheshe, et al.
Published: (2022-02-01) -
cAMP-Dependent Signaling and Ovarian Cancer
by: Agnieszka Kilanowska, et al.
Published: (2022-11-01)